Inherited Human Prion Diseases
Neurol 40:1820-1827, Hsiao,K.&Prusiner,S.B., 1990
Adverse Drug Effects on Neuromuscular Transmission
Semin Neurol 10:89-102, Howard,J.F., 1990
Seizure Risk with Recurrent Alcohol Detoxification
Arch Neurol 47:535-538, Lechtengery,R.&Worner,T.M., 1990
The Evolution of Oral Contraceptives Maximizing Efficacy, Minimizing Risks
Acta Obstet Gynecol Scand (Suppl) 152:7-12990., Hedon,B., 1990
Changing Attitudes and Practices in Forgoing Life-Sustaining Treatments
JAMA 263:2211-2215, 22211990., Sprung,C.L., 1990
Headache Caused by Caffeine Withdrawal Among Moderate Coffee Drinkers Switched to Decaf Coffee
BMJ 300:1558-1559, VanDusseldorp,M.&Katan,M.B., 1990
The Marinesco-Sjogren Syndrome Examined by CT, MR, and 18F-2-Fluoro-2-Deoxy-D-Glucose & PET
Arch Neurol 47:1239-1242, Bromberg,M.B.,et al, 1990
Infantile CNS Spongy Degeneration-14 Cases:Clinical Update
Neurol 40:1876-1882, Gascon,G.G.,et al, 1990
A Follow-up Study of Intractable Seizures in Childhood
Ann Neurol 28:699-705, Huttenlocher,P.R.&Hapke,R.J., 1990
Seizure Recurrence After a 1st Unprovoked Seizure:An Extended Follow-up
Neurol 40:1163-1170, Hauser,W.A.,et al, 1990
Risk of Seizure Recurrence Following a First Unprovoked Seizure in Childhood
Pediatrics 85:1076-1085, Shinnar,S.,et al, 1990
Status Epilepticus Following Withdrawal of Allopurinal
Ann Neurol 27:691, Kramer,L.D.,et al, 1990
Managing Seizures in the Casualty Department
BMJ 300:978-979, McKee,P.J.W.,et al, 1990
Diagnosis of Epilepsy
Lancet 336:291-295, Chadwick,D., 1990
Epilepsy Octet, Epidemiology, Classification, Natural History, and Genetics of Epilepsy
Lancet 336:93-96, Shorvon,S.D., 1990
Auras and Subclinical Seizures:Characteristics and Prognostic Significance
Ann Neurol 28:320-328, Sperling,M.R.&O'Connor,M.J., 1990
The Infant with Anencephaly
Med Task Force on Anencephaly, NEJM 322:669-6741990., , 1990
Vigabatrin
BMJ 300:277-278, 1990, Reynolds,E.H., 1990
Cognitive Change Following MPTP Exposure
Neurol 40:261-264, Stern,Y.,et al, 1990
Withholding and Withdrawal of Life Support from the Critically Ill
NEJM 322:309-315, Smedira,N.G.,et al, 1990
Persistent Vegetative State and the Decision to Withdraw or Withhold Life Support
Council Report, JAMA 263:426-4301990., , 1990
Persistent Vegetative State
Correspondence, Neurol 40:384-3861990., , 1990
Movement Disorders in Alcoholism:A Review
Neurol 40:741-746, Neiman,J.,et al, 1990
Rapid Detection of Creutzfeldt-Jakob Disease and Scrapie Prion Porteins
Neurol 40:110-117, Serban,D.,et al, 1990
Drugs Acting on 5-Hydroxytryptamine Receptors
Editorial, Lancet 2:717-7191989., , 1989
Phenytoin Withdrawal and Seizure Frequency
Neurol 39:905-909, Bromfield,E.B.,et al, 1989
A Randomized Study of Carbamazepine Versus No Medication after a First Unprovoked Seizure in Childhood
Neurol 39:851-852, Camfield,P.,et al, 1989
Aggressive Management of Severe Closed Head Trauma:Time for Reappraisal
Lancet 2:369-371, Gibson,R.M.&Stephenson,G.C., 1989
Gamma-Hydroxybutyric Acid for Treatment of Alcohol Withdrawal Syndrome
Lancet 2:787-789, Gallimberti,L.,et al, 1989
Risk Associated with Heparin Withdrawal in Ischaemic Cerebrovascular Disease
JNNP 52:1332-1336, Slivka,A.,et al, 1989
Metoclopramide-Induced Movement Disorders
Arch Int Med 149:2486-2492, Miller,L.G.&Jankovic,J., 1989
Controlled Release of Dopamine from a Polymeric Brain Implant:In Vivo Characterization
Ann Neurol 25:351-356, During,M.J.,et al, 1989
Brain Death in the Newborn
Pediatrics 84:429-437, Ashwal,S.&Schneider,S., 1989
Guidelines on the Vegetative State:Commentary on the American Academy of Neurology Statement
Neurol 39:123-124, Munsat,T.L.,et al, 1989
Position of the American Academy of Neurology on Certain Aspects of the Care and Management of the Persistent Vegetative State Patient
Neurol 39:125-126, , 1989
Delirium in the Elderly Patient
NEJM 320:578-582, Lipowski,Z.J., 1989
Low Morbidity and Mortality of Status Epilepticus in Children
Pediatrics 83:323-331, Maytal,J.,et al, 1989
Status Epilepticus:It's Not What We've Thought or Taught
Pediatrics 83:444-445, Freemen,J.M., 1989
Etiology and Mortality of Status Epilepticus in Children, A Recent Update
Arch Neurol 46:74-76, Phillips,S.A.&Shanahan,R.J., 1989
Physiology & Pharmacology of Dopamine D2-Receptors:Their Implications in Dopamine-Substitute Therapy for Park
Neurol 39:1106-1108, Mercuri,N.B.,et al, 1989
Postmortem Analysis of Adrenal-Medulla-to-Caudate Autograft in a Patient with Parkinson's Disease
Ann Neurol 25:607-614, Hurtig,H.,et al, 1989
Ethanol and the Nervous System
NEJM 321:442-454, Charness,M.E.,et al, 1989
Ethics of Life Support in Patients with Severe Stroke
Stroke 20:1107-1112, Asplund,K.&Britton,M., 1989
Sleep Abnormalities in Progressive Supranuclear Palsy
Ann Neurol 25:577-581, Aldrich,M.S.,et al, 1989
Clonidine Treatment of Alzheimer's Disease
Arch Neurol 46:376-378, Mohr,E.,et al, 1989
Oculogyric Crisis after Metoclopramide Therapy
Optometry and Vision Science 66:179-180, Edward,M.,et al, 1989
Optimizing Contraceptive Decisions:Clinical Implications of the Triphasic Randomized Clinical Trial
Am J Obstet Gynecol 161:1385-1389, Mishell,D.R., 1989
Life-Threatening Cranial Dystonia Following Trihexyphenidyl Withdrawal
Movement Disorders 4:349-353, Gimenez-Roldan,S.,et al, 1989
MR of Deep Cerebral Venous Thrombosis
Can J Neurol Sci 16:417-421, Ashforth,R.A.,et al, 1989
Possible Benefit of GR43175, A Novel 5-HT1-Like Receptor Agonist for the Acute Treatment of Severe Migraine
Lancet 1:1309-1311, Doenicke,A.,et al, 1988